Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Syringeless contrast media injectors like the GE Ulrich CT Motion have gained a lot of interest in 2022 because of the iodine contrast shortage. These systems use rollers to squeeze precise amounts of contrast from a large bolus container for multiple patients, helping conserve a significant amount of contrast.

Multi-use syringeless injectors could completely eliminate contrast waste

Such products could increase departmental efficiency and advance environmental initiatives in radiology, experts claimed in Academic Radiology.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

physician money payments dollars

Physician-owned hospitals charge less for imaging than their counterparts

The finding comes as lobbying groups urge Congress to repeal an ongoing moratorium on doc hospital ownership

Thumbnail

MRI product developer raises $30M in series A financing, plus more vendor fundraising news

Other imaging-related startup companies recently raising $4.9M or more include Altis Labs, BrainTale, Leadoptik and Hypervision Surgical. 

lung cancer screening

More assertive language in cancer screening reports leads to likelier receipt of follow-up care

Patients with Lung-RADS 4A findings who spoke with a clinician by phone were three times more likely to see things through, experts wrote in JAMA Network Open

MRA for pulmonary embolus

MR angiography a suitable alternative to CT when ruling out pulmonary embolus

The modality switch became especially important during the iodinated contrast shortage of 2022 when clinics were forced to deploy mitigation tactics as a means of preserving their contrast supply. 

Thumbnail

Radiologists read across an average of 5 subspecialties but aren’t always confident doing so

About 40% of rads said they accept studies across all areas of expertise. Yet, less than half are “very confident” reading them. 

Thumbnail

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.